These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 2467994

  • 1. Fine mapping of antigenic site II of herpes simplex virus glycoprotein D.
    Isola VJ, Eisenberg RJ, Siebert GR, Heilman CJ, Wilcox WC, Cohen GH.
    J Virol; 1989 May; 63(5):2325-34. PubMed ID: 2467994
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The contribution of cysteine residues to antigenicity and extent of processing of herpes simplex virus type 1 glycoprotein D.
    Wilcox WC, Long D, Sodora DL, Eisenberg RJ, Cohen GH.
    J Virol; 1988 Jun; 62(6):1941-7. PubMed ID: 2835498
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Localization of epitopes of herpes simplex virus type 1 glycoprotein D.
    Eisenberg RJ, Long D, Ponce de Leon M, Matthews JT, Spear PG, Gibson MG, Lasky LA, Berman P, Golub E, Cohen GH.
    J Virol; 1985 Feb; 53(2):634-44. PubMed ID: 2578577
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Genetic analysis of type-specific antigenic determinants of herpes simplex virus glycoprotein C.
    Dolter KE, Goins WF, Levine M, Glorioso JC.
    J Virol; 1992 Aug; 66(8):4864-73. PubMed ID: 1378512
    [Abstract] [Full Text] [Related]

  • 8. The major neutralizing antigenic site on herpes simplex virus glycoprotein D overlaps a receptor-binding domain.
    Whitbeck JC, Muggeridge MI, Rux AH, Hou W, Krummenacher C, Lou H, van Geelen A, Eisenberg RJ, Cohen GH.
    J Virol; 1999 Dec; 73(12):9879-90. PubMed ID: 10559300
    [Abstract] [Full Text] [Related]

  • 9. Domain structure of herpes simplex virus 1 glycoprotein B: neutralizing epitopes map in regions of continuous and discontinuous residues.
    Pereira L, Ali M, Kousoulas K, Huo B, Banks T.
    Virology; 1989 Sep; 172(1):11-24. PubMed ID: 2475970
    [Abstract] [Full Text] [Related]

  • 10. Use of synthetic peptides to map the antigenic determinants of glycoprotein D of herpes simplex virus.
    Strynadka NC, Redmond MJ, Parker JM, Scraba DG, Hodges RS.
    J Virol; 1988 Sep; 62(9):3474-83. PubMed ID: 2457115
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K, Tomaras GD, Jegaskanda S, Moody MA, Liao HX, Goodman KN, Berman PW, Rerks-Ngarm S, Pitisuttithum P, Nitayapan S, Kaewkungwal J, Haynes BF, Cohen JI.
    J Virol; 2017 Oct 01; 91(19):. PubMed ID: 28701403
    [Abstract] [Full Text] [Related]

  • 13. Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM.
    Nicola AV, Ponce de Leon M, Xu R, Hou W, Whitbeck JC, Krummenacher C, Montgomery RI, Spear PG, Eisenberg RJ, Cohen GH.
    J Virol; 1998 May 01; 72(5):3595-601. PubMed ID: 9557640
    [Abstract] [Full Text] [Related]

  • 14. Intratypic variations in neutralizable epitopes among herpes simplex virus type 2 isolates.
    Bhattarakosol P, Yoosook C, Matangkasombut P.
    Microbiol Immunol; 1991 May 01; 35(7):525-33. PubMed ID: 1723784
    [Abstract] [Full Text] [Related]

  • 15. Characterization of the antigenic structure of herpes simplex virus type 1 glycoprotein C through DNA sequence analysis of monoclonal antibody-resistant mutants.
    Wu CT, Levine M, Homa F, Highlander SL, Glorioso JC.
    J Virol; 1990 Feb 01; 64(2):856-63. PubMed ID: 1688628
    [Abstract] [Full Text] [Related]

  • 16. Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody.
    Cohen GH, Dietzschold B, Ponce de Leon M, Long D, Golub E, Varrichio A, Pereira L, Eisenberg RJ.
    J Virol; 1984 Jan 01; 49(1):102-8. PubMed ID: 6197535
    [Abstract] [Full Text] [Related]

  • 17. Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration.
    Highlander SL, Sutherland SL, Gage PJ, Johnson DC, Levine M, Glorioso JC.
    J Virol; 1987 Nov 01; 61(11):3356-64. PubMed ID: 2444713
    [Abstract] [Full Text] [Related]

  • 18. Intratypic variation of herpes simplex virus type 2 isolates detected by monoclonal antibodies against viral glycoproteins.
    Bhattarakosol P, Yoosook C, Cross A.
    Arch Virol; 1990 Nov 01; 115(1-2):89-100. PubMed ID: 1701081
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.